Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Calcified NCC~* Perilesional edema on CT or MRI~* Normal lab values~Exclusion Criteria:~* Viable neurocysticercosis~* Status epilepticus~* Symptomatic intracranial hypertension~* Tuberculosis~* More than 7 days after seizure~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Acetazolamide (Type: ACTIVE_COMPARATOR): 750 mg acetazolamide p.o. divided in three dily doses, for 10 days
- Dexamethasone (Type: ACTIVE_COMPARATOR): 8 mg p.o. divided in three daily daily doses, for 2 days followed by gradual tapering
- No additional anti-edema treatment (Type: NO_INTERVENTION): No additional treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).